Ivenix said today that its infusion system won 510(k) clearance from the FDA. The large-volume pump and infusion system features a “smartphone-like” user interface and a suite of administration tools to remotely monitor infusions, according to Ivenix. Get the full story at our sister site, Drug Delivery Business News.
Ivenix raised $10 million in equity from 18 unnamed investors in the 1st tranche of its $50 million round, according to regulatory filings. The company indicated that it does not expect the offering to exceed 1 year. It has not made a formal statement about how it plans to spend the newly-acquired funds. The Massachusetts-based start-up […]
Ivenix CEO Stuart Randle began his foray into drug pump delivery systems at Baxter in 1988, when he led the company’s effort to develop the 1st needle-free IV system. More than 20 years later, when he was approached about the corner office at Ivenix, Randle revisited the infusion pump industry and saw that the technology had not kept up […]
Ivenix said in named former GI Dynamics (ASX:GID) chief Stuart Randle to be its new CEO. Randle departed GI Dynamics in August 2014, after 10 years with the bariatric device maker. Amesbury, Mass.-based Ivenix, which raised $42 million last September, is developing an infusion management system for hospitals that will combine an information technology interface […]
Drug infusion device developer Ivenix said today it closed a $42 million round of equity financing to support the company’s efforts to enter the global drug infusion market. Ivenix is developing an infusion management system for hospitals that will combine an information technology interface along with an adaptive fluid delivery platform, the company said. The company hopes […]